ENCell Signs 600 Million Won Biopharmaceutical Supply Contract
ENCell announced on April 20 that it has signed a contract worth 600 million won for the manufacture and supply of advanced biopharmaceuticals.
The contract amount represents 11.41% of the company's sales, which total approximately 5.26 billion won. The contract period runs from today until July 31, 2027.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The company explained, "The payment will be made in installments according to the completion of each phase, starting with a 100 million won down payment, followed by steps such as aseptic process simulation and the production of investigational drugs."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.